Journal article · 2000

Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial

Ronald D. Feld, Ben E. dePauw, Steven Berman, Armand Keating, Winston G. Ho

Journal of Clinical Oncology, 18(21), 3690–3698 · Published 1 November 2000 · DOI 10.1200/jco.2000.18.21.3690

View at the publisherCite this paper

In brief

“Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial” is a 2000 journal article by Ronald D. Feld and 4 co-authors, published in Journal of Clinical Oncology. OpenAlex counts 118 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
118
Most cited in
2016 (4)
Field-weighted impact
2.60
References
30
Authors
5

Abstract

PURPOSE: To compare meropenem, a carbapenem antibiotic, with ceftazidime for the empirical treatment of patients with febrile neutropenia. PATIENTS AND METHODS: A prospective, double-blind, randomized clinical trial was conducted at medical centers in North America and the Netherlands. A total of 411 cancer patients (196 treated with meropenem and 215 treated with ceftazidime), who had… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Feld, R. D., dePauw, B. E., Berman, S., Keating, A., & Ho, W. G. (2000). Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial. Journal of Clinical Oncology, 18(21), 3690–3698. https://doi.org/10.1200/jco.2000.18.21.3690

MLA 9

Feld, Ronald D., et al. “Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial.” Journal of Clinical Oncology, vol. 18, no. 21, 2000, pp. 3690–3698. https://doi.org/10.1200/jco.2000.18.21.3690.

Chicago

Feld, Ronald D., Ben E. dePauw, Steven Berman, Armand Keating, and Winston G. Ho. 2000. “Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial.” Journal of Clinical Oncology 18 (21): 3690–3698. https://doi.org/10.1200/jco.2000.18.21.3690.

Harvard

Feld, R. D. et al. (2000) ‘Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial’, Journal of Clinical Oncology, 18(21), pp. 3690–3698. doi:10.1200/jco.2000.18.21.3690.

IEEE

R. D. Feld, B. E. dePauw, S. Berman, A. Keating, and W. G. Ho, “Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial,” Journal of Clinical Oncology, vol. 18, no. 21, pp. 3690–3698, 2000, doi: 10.1200/jco.2000.18.21.3690.

BibTeX

@article{feld2000meropenem,
  title     = {{Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial}},
  author    = {Feld, Ronald D. and dePauw, Ben E. and Berman, Steven and Keating, Armand and Ho, Winston G.},
  journal   = {Journal of Clinical Oncology},
  year      = {2000},
  volume    = {18},
  number    = {21},
  pages     = {3690--3698},
  doi       = {10.1200/jco.2000.18.21.3690},
  url       = {https://doi.org/10.1200/jco.2000.18.21.3690}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201644
201711
201822
201933
202033
202122
202211
202311
202422
202522

Its field-weighted citation impact is 2.60: it has been cited 2.60 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections

  • meropenem
  • ceftazidime
  • febrile neutropenia
  • cancer patients
  • empirical antibiotic therapy
  • carbapenems
  • bone marrow transplant recipients
  • antibiotic prophylaxis

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Feld, R. D., dePauw, B. E., Berman, S., Keating, A., & Ho, W. G. (2000). Meropenem Versus Ceftazidime in the Treatment of Cancer Patients With Febrile Neutropenia: A Randomized, Double-Blind Trial. Journal of Clinical Oncology, 18(21), 3690–3698. https://doi.org/10.1200/jco.2000.18.21.3690

How many times has this paper been cited?

118 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Ronald D. Feld, Ben E. dePauw, Steven Berman, Armand Keating, Winston G. Ho.

What is the DOI of this paper?

10.1200/jco.2000.18.21.3690, permanently at https://doi.org/10.1200/jco.2000.18.21.3690. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.